YM Biosciences Inc - Report of Foreign Issuer (6-K)
2008年4月14日 - 10:25PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private
Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of
1934
For the
month of April 2008
Commission
File Number: 001-32186
YM BIOSCIENCES
INC.
(Translation of registrant's
name into English)
|
|
Suite 400, Building
11,
5045 Orbiter
Drive
Mississauga,
Ontario
Canada L4W
4Y4
(Address of principal
executive offices)
|
Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
o
Indicate
by check mark whether by furnishing the information contained in this Form the
registrant is also thereby furnishing
the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
If “Yes”
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- ________
INCORPORATION
BY REFERENCE
This
Form 6-K is hereby incorporated by reference into the registration statements on
Form S-8 (File No. 333-134410), Form F-10 (File No131250) and Form F-3 (File No.
120153) of YM BioSciences Inc.
DOCUMENTS FILED
See
the Exhibit Index hereto for a list of the documents filed herewith and forming
a part of this Form 6-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
YM BIOSCIENCES
INC.
|
|
By:
|
/s/
Leonard Vernon
|
|
|
Leonard
Vernon
Vice
President, Finance and
Administration
|
Date: April
11, 2008
EXHIBIT
LIST
Exhibit
|
|
Description
|
99.1
|
|
News Release
dated April 11, 2008
-
YM
BIOSCIENCES ANNOUNCES PRESENTATIONS FOR TWO OF ITS ANTI-CANCER DRUGS AT
AACR ANNUAL MEETING
|
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 6 2024 まで 7 2024
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about YM Biosciences Ordinary Shares (Canada) (アメリカ証券取引所): 0 recent articles
その他のYM Biosciences Incニュース記事